Representative Matters
Back to all Representative Matters
Representative Matter

Aleafia Health Completes Debenture Amendment Transaction and Private Placement

Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann, Jill P. Fraser, Derek J. McCallum, Barbara Worndl and Angelo Gentile
On June 27, 2022, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF), a vertically integrated and federally licensed Canadian cannabis company, closed its amendment of its unsecured convertible debentures and, in connection with the closing of the transaction, a private placement of units. 

The debenture amendments were effected by the exchange of the outstanding $37,049,000 principal amount of unsecured debentures for new, secured convertible debentures, which were issued to existing debenture holders in three equal, separate series and are secured against certain assets of Aleafia Health. 

Aird & Berlis represented Aleafia Health with a team comprised of Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann, Jill Fraser, Angela Oh, Derek McCallum, Barbara Worndl and Angelo Gentile.

Related Areas of Expertise

Industries

Representative Matters